Peer-reviewedCC BY-NC 4.0STAR Protocols
Protocol for engineering primary human and mouse T cells using peptide-assisted genome editing
- 1School of Basic Medical Sciences, Center for Big Data and Population Health of IHM, Anhui Medical University, Hefei, Anhui 230032, China
- 2Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, Anhui 230601, China
- 3Department of Neurobiology, Harbin Medical University, Heilongjiang Provincial Key Laboratory of Neurobiology, Harbin, Heilongjiang 150081, China
Abstract
Efficient engineering of human and murine primary T cells without perturbation of cellular function is crucial for immunotherapy and immunology research. Here, we present a protocol for genome editing of primary T cells with minimal toxicity using peptide-assisted genome editing. We describe key steps required for primary T cell isolation and activation, CRISPR ribonucleoprotein (RNP) assembly and delivery mediated by peptide, and assessment of editing efficiency. This protocol maintains T cell proliferative capacity and functional potency.
For complete details on the use and execution of this protocol, please refer to Zhang et al.1
Related
- Protocol for non-viral HDR-based CRISPR/Cas9 platform for small custom editing in primary T cells
- Prime editing for precise genome engineering and modulation of fungal metabolism
- Protocol for comprehensive genotyping of nuclease, base, and prime editing outcomes using CleanFinder
- Structure- and Exonuclease-Guided Engineering of Cas12o1 Enhances Genome Editing Efficiency and Deletion Outcomes
- Protocol for eVLP-mediated CRISPR-Cas9 and prime editing in pancreatic cancer cell lines
BibTeX
@article{wang2026protocol,
title = {{Protocol for engineering primary human and mouse T cells using peptide-assisted genome editing}},
author = {Jianong Wang and Yifan He and Zhen Zhang},
journal = {STAR Protocols},
year = {2026},
month = nov,
doi = {10.1016/j.xpro.2026.104933},
url = {https://doi.org/10.1016/j.xpro.2026.104933},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Protocol for engineering primary human and mouse T cells using peptide-assisted genome editing
AU - Jianong Wang
AU - Yifan He
AU - Zhen Zhang
PY - 2026
DA - 2026/11/01
JO - STAR Protocols
DO - 10.1016/j.xpro.2026.104933
UR - https://doi.org/10.1016/j.xpro.2026.104933
AB - Efficient engineering of human and murine primary T cells without perturbation of cellular function is crucial for immunotherapy and immunology research. Here, we present a protocol for genome editing of primary T cells with minimal toxicity using peptide-assisted genome editing. We describe key steps required for primary T cell isolation and activation, CRISPR ribonucleoprotein (RNP) assembly and delivery mediated by peptide, and assessment of editing efficiency. This protocol maintains T cell proliferative capacity and functional potency. For complete details on the use and execution of this protocol, please refer to Zhang et al.1
SN - 2666-1667
ER -